Download PDF
Semin Thromb Hemost 2000; 26(5): 451-462
DOI: 10.1055/s-2000-13201
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Hemostatic Protease Receptors and Endothelial Cell Function: Insights from Gene Targeting in Mice

Klaus T. Preissner
  • Institute for Biochemistry, Fachbereich Humanmedizin, Justus-Liebig-Universität, Giessen, Germany
Further Information

Publication History

Publication Date:
31 December 2000 (online)

    Permissions and Reprints

ABSTRACT

Hemostasis constitutes a major defense system of our body that maintains blood flow in the circulation and prevents life-threatening blood loss. The endothelium plays a crucial dynamic role as a protective interface between blood and the underlying tissues during this process. Following vessel wall injury with initial platelet adhesion and aggregation to exposed subendothelial extracellular matrix, the initiation, amplification, and control of hemostasis depend on structurally unrelated membrane-associated receptors for blood coagulation proteases including tissue factor, G protein-coupled protease-activatable receptors, thrombomodulin, or protein C receptor. In addition to their regulatory role in hemostasis, the respective (pro-)enzyme ligands such as factors VIIa and Xa, thrombin, and protein C mediate specific signaling pathways in vascular cells related to migration, proliferation, or adhesion. The functional importance of these receptors beyond hemostasis has been manifested by various lethal or pathological phenotypes in knock-out mice. These protease receptors thereby provide important molecular links in the vascular system and serve to integrate hemostasis with endothelial cell functions that are relevant for the (patho-) physiological responses to inflammatory challenges, injury, or infection.

KEYWORD

Hemostasis - endothelium - receptors - proteases - mice

REFERENCES

  • 1 Risau W. Mechanisms of angiogenesis.  Nature . 1997;  386 671-674
    CrossrefPubMedGoogle Scholar
  • 2 Springer T A. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm.  Cell . 1994;  76 301-314
    CrossrefPubMedGoogle Scholar
  • 3 Zimmerman G A, McIntyre T M, Prescott S M. Adhesion and signalling in vascular cell-cell interactions.  J Clin Invest . 1996;  98 1699-1702
    CrossrefPubMedGoogle Scholar
  • 4 May A E, Neumann F J, Preissner K T. The relevance of blood cell-vessel wall adhesive interactions for vascular thrombotic disease.  Thromb Haemost . 1999;  82 962-970
    PubMedGoogle Scholar
  • 5 Cines D B, Pollak E S, Buck C A. Endothelial cells in physiology and in the pathophysiology of vascular disorders.  Blood . 1998;  91 3527-3561
    PubMedGoogle Scholar
  • 6 Bu G, Warshawsky I, Schwartz A L. Cellular receptors for the plasminogen activators.  Blood . 1994;  83 3427-3436
    PubMedGoogle Scholar
  • 7 Anderson R GW. The caveolae membrane system.  Annu Rev Biochem . 1998;  67 199-225
    CrossrefPubMedGoogle Scholar
  • 8 Schnitzer J E, McIntosh D P, Dvorak A M, Liu J, Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins.  Science . 1995;  269 1435-1439
    PubMedGoogle Scholar
  • 9 Blasi F. uPA, uPAR, PAI-1: Key intersection of proteolytic, adhesive and chemotactic highways?.  Immunol Today . 1997;  18 415-417
    CrossrefPubMedGoogle Scholar
  • 10 Carmeliet P, Collen D. Role of the plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis.  Trends Cardiovasc Med . 1995;  5 117-122
    CrossrefPubMedGoogle Scholar
  • 11 Carmeliet P, Collen D. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system.  Thromb Res . 1998;  91 255-286
    CrossrefPubMedGoogle Scholar
  • 12 Konigsberg W H, Nemerson Y. Molecular cloning of the cDNA for human tissue factor.  Cell . 1988;  52 639-640
    PubMedGoogle Scholar
  • 13 Martin D MA, Boys C WG, Ruf W. Tissue factor: Molecular recognition and cofactor function.  FASEB J . 1995;  9 852-859
    PubMedGoogle Scholar
  • 14 Morrissey J H, Neuenschwander P F, Huang Q. Factor VIIa-tissue factor: Functional importance of protein-membrane interactions.  Thromb Haemost . 1997;  78 112-116
    PubMedGoogle Scholar
  • 15 Ruf W, Edgington T S. Structural biology of tissue factor, the initiator of thrombogenesis in vivo.  FASEB J . 1994;  8 385-390
    PubMedGoogle Scholar
  • 16 Gailani D, Broze G J. Factor XI activation in a revised model of blood coagulation.  Science . 1991;  253 909-911
    CrossrefPubMedGoogle Scholar
  • 17 Giesen P L, Rauch U, Bohrmann B. Blood-borne tissue factor: Another view of thrombosis.  Proc Natl Acad Sci USA . 1999;  96 2311-2315
    Google Scholar
  • 18 Holzmuller H, Moll T, Hofer-Warbinek R. A transcriptional repressor of the tissue factor gene in endothelial cells.  Arterioscler Thromb Vasc Biol . 1999;  19 1804-1811
    PubMedGoogle Scholar
  • 19 Weiss H J, Turitto V T, Baumgartner H R, Nemerson Y, Hoffmann T. Evidence for the presence of tissue factor activity on subendothelium.  Blood . 1989;  73 968-975
    PubMedGoogle Scholar
  • 20 Contrino J, Hair G, Kreutzer D L, Rickles F R. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease.  Nat Med . 1996;  2 209-215
    CrossrefPubMedGoogle Scholar
  • 21 Drake T A, Cheng J, Chang A, Taylor F B. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis.  Am J Pathol . 1993;  142 1458-1470
    PubMedGoogle Scholar
  • 22 Wilcox J N, Smith K M, Schwartz S M, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.  Proc Natl Acad Sci USA . 1989;  86 2839-2843
    PubMedGoogle Scholar
  • 23 Annex B H, Denning S M, Channon K M. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes.  Circulation . 1995;  91 619-622
    PubMedGoogle Scholar
  • 24 Kaikita K, Takeya M, Ogawa H. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.  J Pathol . 1999;  188 180-188
    PubMedGoogle Scholar
  • 25 Brand K, Banka C L, Mackman N. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes.  Arterioscler Thromb . 1994;  14 790-797
    PubMedGoogle Scholar
  • 26 Taubman M B, Fallon J T, Schecter A D. Tissue factor in the pathogenesis of atherosclerosis.  Thromb Haemost . 1997;  78 200-204
    PubMedGoogle Scholar
  • 27 Bauer K A. Activation of the factor VII-tissue factor pathway.  Thromb Haemost . 1997;  78 108-111
    PubMedGoogle Scholar
  • 28 Mulder A B, Smit J W, Blom N R. Association of smooth muscle cell tissue factor with caveolae.  Blood . 1996;  88 1306-1313
    PubMedGoogle Scholar
  • 29 Lupu C, Goodwin C A, Westmuckett A D. Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium.  Arterioscler Thromb Vasc Biol . 1997;  17 2964-2974
    CrossrefPubMedGoogle Scholar
  • 30 Sevinsky J R, Rao L VM, Ruf W. Ligand-induced protease receptor translocation into caveolae: A mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.  J Cell Biol . 1996;  133 293-304
    Google Scholar
  • 31 Huang Z-F, Higuchi D, Lasky N, Broze G J. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.  Blood . 1997;  90 944-951
    PubMedGoogle Scholar
  • 32 Zhang Y, Deng Y, Wendt T. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-α-induced tissue factor expression and fibrin deposition in mouse meth-a sarcomas.  J Clin Invest . 1996;  97 2213-2224
    PubMedGoogle Scholar
  • 33 Bugge T H. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.  Proc Natl Acad Sci USA . 1996;  93 6258-6263
    CrossrefPubMedGoogle Scholar
  • 34 Carmeliet P, Mackman N, Moons L. Role of tissue factor in embryonic blood vessel development.  Nature . 1996;  383 73-75
    CrossrefPubMedGoogle Scholar
  • 35 Toomey J R, Kratzer K E, Lasky N M, Stanton J J, Broze G J. Targeted disruption of the murine tissue factor gene results in embryonic lethality.  Blood . 1996;  88 1583-1587
    PubMedGoogle Scholar
  • 36 Toomey J R, Kratzer K E, Lasky N M, Broze G J. Effect of tissue factor deficiency on mouse and tumor development.  Proc Natl Acad Sci USA . 1997;  94 6922-6926
    CrossrefPubMedGoogle Scholar
  • 37 Parry G CN, Erlich J H, Carmeliet P, Luther T, Mackman N. Low levels of tissue factor are compatible with development and hemostasis in mice.  J Clin Invest . 1998;  101 560-569
    CrossrefPubMedGoogle Scholar
  • 38 Erlich J, Parry G C, Fearns C. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation.  Proc Natl Acad Sci USA . 1999;  96 8138-8143
    CrossrefPubMedGoogle Scholar
  • 39 Clauss M, Grell M, Fangmann C. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: Functional analysis of the tumor necrosis factor receptors.  FEBS Lett . 1996;  390 334-338
    CrossrefPubMedGoogle Scholar
  • 40 Zhang Y, Deng Y, Luther T. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.  J Clin Invest . 1994;  94 1320-1327
    Google Scholar
  • 41 Rosen E D, Chan J C, Idusogie E. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.  Nature . 1997;  390 290-294
    CrossrefPubMedGoogle Scholar
  • 42 Chan J CY, Carmeliet P, Moons L. Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.  J Clin Invest . 1999;  103 475-482
    PubMedGoogle Scholar
  • 43 Ruf W, Mueller B M. Tissue factor signaling.  Thromb Haemost . 1999;  82 175-182
    PubMedGoogle Scholar
  • 44 Edgington T S, Dickinson C D, Ruf W. The structural basis of function of the TF-VIIa complex in the cellular initiation of coagulation.  Thromb Haemost . 1997;  78 401-405
    PubMedGoogle Scholar
  • 45 Bromberg M E, Sundaram R, Homer R J, Garen A, Konigsberg W H. Role of tissue factor in metastatsis: Functions of the cytoplasmic and extracellular domains of the molecule.  Thromb Haemost . 1999;  82 88-92
    PubMedGoogle Scholar
  • 46 Zioncheck T F, Roy S, Vehar G A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase-C-dependent mechanism.  J Biol Chem . 1992;  267 3561-3564
    PubMedGoogle Scholar
  • 47 Mueller B M, Reisfeld R A, Edgington T S, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.  Proc Natl Acad Sci USA . 1992;  89 11832-11836
    PubMedGoogle Scholar
  • 48 Mueller B M, Ruf W. Requirement for binding of catalytically factor VIIa in tissue factor-dependent experimental metastasis.  J Clin Invest . 1998;  101 1372-1378
    Google Scholar
  • 49 Ott I, Fischer E G, Miyagi Y, Möller B M, Ruf W. A role of tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280.  J Cell Biol . 1998;  140 1241-1253
    Google Scholar
  • 50 Randolph G J, Luther T, Albrecht S, Magdolen V, Muller W A. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro.  Blood . 1998;  92 4167-4177
    PubMedGoogle Scholar
  • 51 Brinkman H J, Mertens K, Holthuis J. The activation of human blood coagulation factor X on the surface of endothelial cells: A comparison with various vascular cells, platelets and monocytes.  Br J Haematol . 1994;  87 332-342
    PubMedGoogle Scholar
  • 52 Stern D M, Knitter G, Kisiel W, Nawroth P P. In vivo evidence of intravascular binding sites for coagulation factor IX.  Br J Haematol . 1987;  66 227-232
    PubMedGoogle Scholar
  • 53 Tijburg P, Ryan J, Stern D M. Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa.  J Biol Chem . 1991;  266 12067-12074
    PubMedGoogle Scholar
  • 54 Cheung W F, van den Born J, Köhn K. Identification of the endothelial cell binding site for factor IX.  Proc Natl Acad Sci USA . 1996;  93 11068-11073
    CrossrefPubMedGoogle Scholar
  • 55 Stern D M, Nawroth P P, Kisiel W. A coagulation pathway on bovine aortic segments leading to generation of factor Xa and thrombin.  J Clin Invest . 1984;  74 1910-1921
    PubMedGoogle Scholar
  • 56 Etingin O R, Silverstein R L, Friedman H M, Hajjar D P. Viral activation of the coagulation cascade: Molecular interactions at the surface of infected endothelial cells.  Cell . 1990;  61 657-662
    CrossrefPubMedGoogle Scholar
  • 57 Altieri D C, Etingin O R, Fair D S. Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors.  Science . 1991;  254 1200-1202
    PubMedGoogle Scholar
  • 58 Cui J, O'Shea K S, Purkayastha A, Saunders T L, Ginsburg D. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V.  Nature . 1996;  384 66-68
    CrossrefPubMedGoogle Scholar
  • 59 Nichols W C, Seligsohn U, Zivelin A. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII.  Cell . 1998;  93 61-70
    CrossrefPubMedGoogle Scholar
  • 60 Altieri D C. Coagulation assembly on leukocytes in transmembrane signaling and cell adhesion.  Blood . 1993;  81 569-579
    PubMedGoogle Scholar
  • 61 Altieri D C. Xa receptor EPR-1.  FASEB J . 1995;  9 860-865
    PubMedGoogle Scholar
  • 62 Bouchard B A, Catcher C S, Thrash B R, Adida C, Tracy P B. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation.  J Biol Chem . 1997;  272 9244-9251
    CrossrefPubMedGoogle Scholar
  • 63 Gajdusek C, Carbon S, Ross R, Nawroth P, Stern D. Activation of coagulation releases endothelial cell mitogens.  J Cell Biol . 1986;  103 419-428
    CrossrefPubMedGoogle Scholar
  • 64 Altieri D C. Proteases and protease receptors in modulation of leukocyte effector functions.  J Leukoc Biol . 1995;  58 120-127
    PubMedGoogle Scholar
  • 65 Herbert J M, Bono F, Herault J P. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.  J Clin Invest . 1998;  101 993-1000
    PubMedGoogle Scholar
  • 66 Cirino G, Cicala C, Bucci M. Factor Xa as an interface between coagulation and inflammation: Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.  J Clin Invest . 1997;  99 2446-2451
    PubMedGoogle Scholar
  • 67 Hattori R, Hamilton K K, Fugate R D, McEver R P, Sims P J. Stimulated secretion of endothelial vWF is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140.  J Biol Chem . 1989;  264 7768-7771
    PubMedGoogle Scholar
  • 68 Colotta F, Sciacca F L, Sironi M. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin.  Am J Pathol . 1994;  144 975-985
    PubMedGoogle Scholar
  • 69 McNamara C A, Sarembock I J, Gimple L W. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.  J Clin Invest . 1993;  91 94-98
    PubMedGoogle Scholar
  • 70 Herbert J M, Dupuy E, Laplace M C. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway.  Biochem J . 1994;  303 227-231
    PubMedGoogle Scholar
  • 71 Kanthou C, Benzakour O. Cellular effects of thrombin and their signalling pathways.  Cell Pharmacol . 1995;  2 293-302
    PubMedGoogle Scholar
  • 72 Coughlin S R. Molecular mechanisms of thrombin signaling.  Semin Hematol . 1994;  31 270-277
    PubMedGoogle Scholar
  • 73 Coughlin S R. Protease-activated receptors and platelet function.  Thromb Haemost . 1999;  82 353-356
    PubMedGoogle Scholar
  • 74 Scarborough R M, Naughton M A, Teng W. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.  J Biol Chem . 1992;  267 13146-13149
    PubMedGoogle Scholar
  • 75 Trejo J, Hammes S R, Coughlin S R. Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting.  Proc Natl Acad Sci USA . 1998;  95 13698-13702
    CrossrefPubMedGoogle Scholar
  • 76 Vu T-KV, Hung D T, Wheaton V I, Coughlin S R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.  Cell . 1991;  64 1057-1068
    CrossrefPubMedGoogle Scholar
  • 77 Ishihara H, Connolly A J, Zeng D. Protease-activated receptor 3 is a second thrombin receptor in humans.  Nature . 1997;  386 502-506
    CrossrefPubMedGoogle Scholar
  • 78 Kahn M L, Zheng Y W, Huang W. A dual thrombin receptor system for platelet activation.  Nature . 1998;  394 690-694
    CrossrefPubMedGoogle Scholar
  • 79 Xu W F, Andersen H, Whitmore T E. Cloning and characterization of human protease-activated receptor-4.  Proc Natl Acad Sci USA . 1998;  95 6642-6646
    CrossrefPubMedGoogle Scholar
  • 80 Coughlin S R. How the protease thrombin talks to cells.  Proc Natl Acad Sci USA . 1999;  96 11023-11027
    CrossrefPubMedGoogle Scholar
  • 81 Connolly A J, Ishihara H, Kahn M L, Farese R V, Coughlin S R. Role of the thrombin receptor in development and evidence for a second receptor.  Nature . 1996;  381 516-519
    CrossrefPubMedGoogle Scholar
  • 82 Xue J, Nu Q, Westfield L A. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice.  Proc Natl Acad Sci USA . 1998;  95 7603-7607
    CrossrefPubMedGoogle Scholar
  • 83 Suh T T, Holmbäck K, Jensen N J. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.  Genes Dev . 1995;  9 2020-2033
    CrossrefPubMedGoogle Scholar
  • 84 Shivdasani R A, Rosenblatt M F, Zucker F D. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.  Cell . 1995;  81 695-704
    CrossrefPubMedGoogle Scholar
  • 85 Even-Ram S, Uziely B, Cohen P. Thrombin receptor overexpression in malignant and physiological invasion processes.  Nature Med . 1998;  4 909-914
    PubMedGoogle Scholar
  • 86 Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor.  Proc Natl Acad Sci USA . 1994;  91 9208-9212
    PubMedGoogle Scholar
  • 87 Brass L F, Molino M. Protease-activated G protein-coupled receptors on human platelets and endothelial cells.  Thromb Haemost . 1997;  78 234-241
    PubMedGoogle Scholar
  • 88 Alm A K, Norstrom E, Sundelin J, Nystedt S. Stimulation of proteinase activated receptor-2 causes endothelial cells to promote blood coagulation in vitro.  Thromb Haemost . 1999;  81 984-988
    PubMedGoogle Scholar
  • 89 Woolkalis M J, DeMelfi T M, Blanchard N, Hoxie J A, Brass L F. Regulation of thrombin receptors on human umbilical vein endothelial cells.  J Biol Chem . 1999;  270 9868-9875
    PubMedGoogle Scholar
  • 90 Sambrano G R, Coughlin S R. The carboxyl tail of protease-activated receptor-1 is required for chemotaxis. Correlation of signal termination and directional migration.  J Biol Chem . 1999;  274 20178-20184
    CrossrefPubMedGoogle Scholar
  • 91 Molino M, Woolkalis M J, Reavey-Cantwell J. Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment.  J Biol Chem . 1997;  272 11133-11141
    CrossrefPubMedGoogle Scholar
  • 92 Bar-Shavit R, Kahn A, Wilner G D, Fenton J W. Monocyte chemotaxis: Stimulation by specific exosite region in thrombin.  Science . 1983;  220 728-731
    PubMedGoogle Scholar
  • 93 Bar-Shavit R, Kahn A J, Mann K G, Wilner G D. Identification of a thrombin sequence with growth factor activity on macrophages.  Proc Natl Acad Sci USA . 1986;  83 976-980
    CrossrefPubMedGoogle Scholar
  • 94 Bar-Shavit R, Kahn A J, Mann K G, Wilner G D. Growth promoting effects of esterolytically inactive thrombin.  J Cell Biol . 1986;  32 261-272
    PubMedGoogle Scholar
  • 95 Bar-Shavit R, Sabbah V, Lampugnani M G. An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion.  J Cell Biol . 1991;  112 335-344
    CrossrefPubMedGoogle Scholar
  • 96 Bar-Shavit R, Eskohjido Y, Fenton J W, Esko J D, Vlodavsky I. Thrombin adhesive properties: Induction by plasmin and heparan sulfate.  J Cell Biol . 1993;  123 1279-1287
    CrossrefPubMedGoogle Scholar
  • 97 Esmon C T. The protein C pathway: new insights.  Thromb Haemost . 1997;  78 70-74
    PubMedGoogle Scholar
  • 98 Ostrovsky L, Woodman R C, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion.  Circulation . 1997;  96 2302-2310
    PubMedGoogle Scholar
  • 99 Wen D, Dittmann W A, Ye R D. Human thrombomodulin: Complete cDNA sequence and chromosome localization of the gene.  Biochemistry . 1987;  26 4350-4357
    CrossrefPubMedGoogle Scholar
  • 100 Suzuki K, Kusumoto H, Deyashiki Y. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation.  EMBO J . 1987;  6 1891-1897
    PubMedGoogle Scholar
  • 101 Parkinson J F, Koyama T, Bang N U, Preissner K T. Thrombomodulin: An anticoagulant cell surface proteoglycan with physiologically relevant glycosaminoglycan moiety. In: Lane DA, Björk I, Lindahl U, eds. Heparin and Related Polysaccharides New York: Plenum, 1992: 177-188
    Google Scholar
  • 102 Ye J, Esmon C T, Johnson A E. The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin.  J Biol Chem . 1993;  268 2373-2379
    PubMedGoogle Scholar
  • 103 Preissner K T, Koyama T, Tschopp J, Müller-Berghaus G. Domain structure of the endothelial cell receptor thrombomodulin as deduced from modulation of its anticoagulant functions. Evidence for a glycosaminoglycan-dependent secondary binding site for thrombin.  J Biol Chem . 1990;  265 4915-4922
    PubMedGoogle Scholar
  • 104 Bourin M C, Lindahl U. Glycosaminoglycans and the regulation of blood coagulation.  Biochem J . 1993;  289 313-330
    PubMedGoogle Scholar
  • 105 Koyama T, Parkinson J F, Aoki N. Relationship between post-translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulin.  Br J Haematol . 1991;  78 515-522
    PubMedGoogle Scholar
  • 106 Esmon C T. Thrombomodulin as a model of molecular mechanism that modulate protease specificity and function at the vessel surface.  FASEB J . 1995;  9 946-955
    PubMedGoogle Scholar
  • 107 Sadler J E. Thrombomodulin structure and function.  Thromb Haemost . 1997;  78 392-395
    PubMedGoogle Scholar
  • 108 Conway E M, Pollefeyt S, Collen D, Steiner-Mosonyi M. The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis.  Blood . 1997;  89 652-661
    PubMedGoogle Scholar
  • 109 Braat E AM, Los P, Rijken D C. The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu:effect of thrombomodulin.  Blood Coagul Fibrinolysis . 1998;  9 419-427
    PubMedGoogle Scholar
  • 110 Nesheim M, Wang W, Boffa M. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.  Thromb Haemost . 1997;  78 386-391
    PubMedGoogle Scholar
  • 111 Rezaie A R, Cooper S T, Church F C, Esmon C T. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex.  J Biol Chem . 1995;  270 25336-25339
    CrossrefPubMedGoogle Scholar
  • 112 Preissner K T. Physiological role of vessel wall related antithrombotic mechanisms: Contribution of endogenous and exogenous heparin-like components to the anticoagulant potential of the endothelium.  Haemostasis . 1990;  20 30-49
    PubMedGoogle Scholar
  • 113 Haley P E, Doyle M F, Mann K G. The activation of bovine protein C by factor Xa.  J Biol Chem . 1989;  264 16303-16310
    PubMedGoogle Scholar
  • 114 Wu Q Y, Tsiang M, Lentz S R, Sadler J E. Ligand specificity of human thrombomodulin-equilibrium binding of human thrombin, meizothrombin, and factor Xa to recombinant thrombomodulin.  J Biol Chem . 1992;  267 7083-7088
    PubMedGoogle Scholar
  • 115 Healy A M, Rayburn H B, Rosenberg R D, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system.  Proc Natl Acad Sci USA . 1995;  92 850-854
    PubMedGoogle Scholar
  • 116 Imada M, Imada S, Iwasaki H. Fetomodulin: Marker surface protein of fetal development which is modulatable by cyclic AMP.  Dev Biol . 1987;  122 483-491
    CrossrefPubMedGoogle Scholar
  • 117 Imada S, Yamaguchi H, Nagumo M. Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays.  Dev Biol . 1990;  140 113-122
    CrossrefPubMedGoogle Scholar
  • 118 Maruyama I, Bell C E, Majerus P W. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.  J Cell Biol . 1985;  101 363-371
    CrossrefPubMedGoogle Scholar
  • 119 Zhang Y, Weiler-Guettler H. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.  J Clin Invest . 1998;  101 1301-1309
    PubMedGoogle Scholar
  • 120 Conway E M. Structure-function analyses of thrombomodulin by gene-targeting in mice: The cytoplasmic domain is not required for normal fetal development.  Blood . 1999;  93 3442-3450
    PubMedGoogle Scholar
  • 121 Fukudome K, Esmon C T. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor.  J Biol Chem . 1994;  269 26486-26491
    PubMedGoogle Scholar
  • 122 Esmon C T. Endothelial protein C receptor.  Thromb Haemost . 1999;  82 251-258
    PubMedGoogle Scholar
  • 123 Mitro L Z, Taylor F BJ, Ferrell G, Esmon C T. Human protein C receptor is present primarily on endothelium of large blood vessels: Implications for the control of the protein C pathway.  Circulation . 1997;  96 3633-3640
    CrossrefPubMedGoogle Scholar
  • 124 Kurosawa S, Stearns-Kurosawa D J, Hidari N, Esmon C T. Identification of functional endothelial protein C receptor in human plasma.  J Clin Invest . 1997;  100 411-418
    PubMedGoogle Scholar
  • 125 Jalbert L R, Rosen E D, Moons L. Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.  J Clin Invest . 1998;  102 1481-1497
    CrossrefPubMedGoogle Scholar
  • 126 Reitsma P H. Protein C deficiency: From gene defects to disease.  Thromb Haemost . 1997;  78 344-350
    PubMedGoogle Scholar
  • 127 Svensson P J, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis.  N Engl J Med . 1994;  330 517-522
    CrossrefPubMedGoogle Scholar
  • 128 Bertina R M, Koeleman B PC, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C.  Nature . 1994;  369 64-67
    CrossrefPubMedGoogle Scholar
  • 129 Öhlin A K, Norlund N, Marlar R A. Thrombomodulin gene variations and thromboembolic disease.  Thromb Haemost . 1997;  78 396-400
    PubMedGoogle Scholar
  • 130 Borgel D, Gandrille S, Aiach M. Protein S deficiency.  Thromb Haemost . 1997;  78 351-356
    PubMedGoogle Scholar
  • 131 Taylor J, Chang A, Esmon C T. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.  J Clin Invest . 1987;  79 918-925
    CrossrefPubMedGoogle Scholar
  • 132 Simmonds R E, Lane D A. Structural and functional implications of the intron/exon organization of the human endothelial cell protein C/activated protein C receptor (EPCR) gene: Comparison with the structure of CD1/major histocompatibility complex alpha1 and alpha2 domains.  Blood . 1999;  94 632-641
    PubMedGoogle Scholar
  • 133 Esmon C T. They're not just for clots anymore: The idenfication of the blood-clotting inhibitor, protein S, as a ligand for a previously ``orphan'' family of receptor tyrosine kinases demonstrates a new role for clotting and anti-clotting proteins in regulating cell proliferation.  Curr Biol . 1995;  5 743-746
    CrossrefPubMedGoogle Scholar
  • 134 Benzakour O, Formstone C, Rahman S. Evidence for a protein S receptor(s) on human vascular smooth muscle cells.  Biochem J . 1995;  308 481-485
    PubMedGoogle Scholar
  • 135 Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade.  Mol Cell Biol . 1993;  13 4976-4985
    PubMedGoogle Scholar
  • 136 Stitt T N, Conn G, Gore M. The anticoagulation factor protein S and its relative, Gas6, are ligands for the tyro 3/Axl family of receptor tyrosine kinases.  Cell . 1995;  80 661-670
    CrossrefPubMedGoogle Scholar
  • 137 He X, Shen L, Bjartell A, Dahlbäck B. Th gene encoding vitamin K-dependent anticoagulant protein S is expressed in multiple rabbit organs as demonstrated by northern blotting, in situ hybridization, and immunohistochemistry.  J Histochem Cytochem . 1995;  43 85-96
    CrossrefPubMedGoogle Scholar
  • 138 Benzakour O, Kanthou C, Kanse S M, Preissner K T. Identification of annexin II as a receptor for the anti-coagulant factor, protein S, in human vascular smooth muscle cells.  Thromb Haemost . 1999;  82(Suppl) 215(Abst)
    PubMedGoogle Scholar
  • 139 Cesarman G M, Guevara C A, Hajjar K A. An endothelial cell receptor for plasminogen tissue-plasminogen activator (t-PA). 2. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.  J Biol Chem . 1994;  269 21198-21203
    PubMedGoogle Scholar
  • 140 Chung C Y, Murphy-Ullrich J E, Erickson H P. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.  Mol Biol Cell . 1996;  7 883-892
    PubMedGoogle Scholar
  • 141 Dahlbäck B. Interaction between complement component C4b-binding protein and the vitamin K-dependent protein S. A link between blood coagulation and the complement system.  Scand J Clin Lab Invest . 1985;  45 33-41
    PubMedGoogle Scholar
  • 142 Menell J S, Cesarman G M, Jacovina A T. Annexin II and bleeding in acute promyelocytic leukemia.  N Engl J Med . 1999;  340 994-1004
    CrossrefPubMedGoogle Scholar
  • 143 Weiler-Guettler H, Christie P D, Beeler D L. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.  J Clin Invest . 1998;  101 1983-1991
    CrossrefPubMedGoogle Scholar
  • 144 Dreyfus M, Magny J F, Bridey F. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate.  N Engl J Med . 1991;  325 1565-1568
    CrossrefPubMedGoogle Scholar
  • 145 Richardson M A, Gerlitz B, Grinnell B W. Enhancing protein C interaction with thrombin results in a clot-activated anticoagulant.  Nature . 1992;  360 261-264
    CrossrefPubMedGoogle Scholar
  • 146 O'Reilly M S, Pirie-Shepherd S, Lane W S, Folkman J. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin.  Science . 1999;  285 1926-1928
    CrossrefPubMedGoogle Scholar
  • 147 Mansuy I M, van der Putten H, Schmid P. Variable and multiple expression of protease nexin-1 during mouse organogenesis and nervous system development.  Development . 1993;  119 1119-1134
    PubMedGoogle Scholar
  • 148 Hoffman M, Pratt C W, Brown R L, Church F C. Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity.  Blood . 1989;  73 1682-1685
    PubMedGoogle Scholar
  • 149 Carmeliet P, Moons L, Collen D. Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis.  Cardiovasc Res . 1998;  39 8-33
    CrossrefPubMedGoogle Scholar
  • 150 Degen J L. Haemostatic factors and inflammatory disease.  Thromb Haemost . 1999;  82 858-864
    PubMedGoogle Scholar
  • 151 Carmeliet P, Moons L, Dewerchin M. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.  Ann NY Acad Sci . 1997;  811 191-206
    PubMedGoogle Scholar
  • 152 Huang X, Molema G, King S. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature.  Science . 1997;  275 547-550
    CrossrefPubMedGoogle Scholar
      >